Archives: Agenda

• Designing compliant multi-language labels across global regions
• Balancing patient-centric packaging with regulatory requirements
• Keeping pace with changing requirements to keep trials moving forward

• Exploring realistic AI applications across planning and distribution
• Managing risks of automation while ensuring compliance
• Sharing lessons learned from early adopters in the industry

• Advanced Modalities, biomarkers, amendments, DCTs, globalization
• How data and early signals can help anticipate shifts in supply chain needs, competitive intelligence and site selection.
• Navigating challenges around CDMO and supply chain vendor planning and selection

During the roundtable discussion session, the conference hall will be divided into three ‘zones’. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within clinical supply chains. After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

ROUNDTABLE 1: Developing comprehensive organizational approaches to interactive response technology (IRT) for efficient supply management
Chris Silva, Vice President, Supply Chain, Procurement and Sourcing, Akebia Therapeutics

ROUNDTABLE 2: Exploring ways of advancing clinical trial supply with RPA, Advanced Analytics and Generative AI
Tomasz Adamusiak, Chief Scientist, Clinical Quality and Data Science, MITRE

ROUNDTABLE 3: Developing a proper Supply Chain and Logistics department in Clinical Phase 1 and 2 with a focus on commercial launch implications
Sebastian Tomlin, Director, Distribution and Logistics, Cullinan Therapeutics
Eric Elbel, Former Associate Director, Logistics, Geron Corporation

• Coordinating across regulatory, logistics, and compliance teams to ensure seamless global shipments
• Anticipating geopolitical and policy shifts that impact trade routes and study timelines
• Strengthening communication with regulators, CROs, and suppliers to reduce delays and risk exposure